help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Berry, M. J.
Right arrow Articles by Larsen, P. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Berry, M. J.
Right arrow Articles by Larsen, P. R.

Endocrinology, Vol 131, 1848-1852, Copyright © 1992 by Endocrine Society


ARTICLES

Substitution of cysteine for selenocysteine in type I iodothyronine deiodinase reduces the catalytic efficiency of the protein but enhances its translation

MJ Berry, AL Maia, JD Kieffer, JW Harney and PR Larsen
Thyroid Division, Brigham and Women's Hospital, Boston, Massachusetts 02115.

Type I iodothyronine 5' deiodinase (5'DI) contains selenocysteine, encoded by a UGA codon, and this amino acid is essential for maximum catalytic efficiency in this enzyme. We recently showed that translation of UGA as selenocysteine in this protein requires a specific sequence of about 250 nucleotides in the 3' untranslated region of the messenger RNA. Translation of a 5'DI cysteine mutant does not require the 3' untranslated region. To examine both the efficiency of UGA codon recognition and the relative catalytic efficiency of selenocysteine vs. cysteine in 5'DI, we used bromoacetyl 125I-T3 labeling to quantitate transiently expressed selenocysteine (wild type) and cysteine containing type I iodothyronine deiodinases in transfected COS-7 and JEG-3 cell lines. Kinetic analyses of the same cell sonicates were performed to determine the apparent maximum velocity and Michaelis- Menten constant values for reverse T3 5' deiodination. COS-7 cells express the cysteine mutant protein at about 20-fold and JEG-3 cells about 400-fold higher levels than the selenoenzyme. However, in both cell types, the apparent catalytic constant values were at least 100- fold higher for the wild-type enzyme, compared with the cysteine mutant. These results indicate that cell lines differ markedly in their capacity to translate UGA-containing messenger RNAs. The much higher catalytic constant values for the selenium-containing enzyme illustrate the biochemical advantage of this element as compared with sulfur in the catalysis of iodothyronine deiodination.


This article has been cited by other articles:


Home page
J EndocrinolHome page
S. M. Wajner, M. dos Santos Wagner, R. C N Melo, G. G Parreira, H. Chiarini-Garcia, A. C Bianco, C. Fekete, E. Sanchez, R. M Lechan, and A. L. Maia
Type 2 iodothyronine deiodinase is highly expressed in germ cells of adult rat testis
J. Endocrinol., July 1, 2007; 194(1): 47 - 54.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
G. D. V. Sagar, B. Gereben, I. Callebaut, J.-P. Mornon, A. Zeold, W. S. da Silva, C. Luongo, M. Dentice, S. M. Tente, B. C. G. Freitas, et al.
Ubiquitination-Induced Conformational Change within the Deiodinase Dimer Is a Switch Regulating Enzyme Activity
Mol. Cell. Biol., July 1, 2007; 27(13): 4774 - 4783.
[Abstract] [Full Text] [PDF]


Home page
RNAHome page
M. T. Howard, M. W. Moyle, G. Aggarwal, B. A. Carlson, and C. B. Anderson
A recoding element that stimulates decoding of UGA codons by Sec tRNA[Ser]Sec
RNA, June 1, 2007; 13(6): 912 - 920.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
E. C. H. Friesema, G. G. J. M. Kuiper, J. Jansen, T. J. Visser, and M. H. A. Kester
Thyroid Hormone Transport by the Human Monocarboxylate Transporter 8 and Its Rate-Limiting Role in Intracellular Metabolism
Mol. Endocrinol., November 1, 2006; 20(11): 2761 - 2772.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. I. C. Simpson, D. M. Leonard, and J. L. Leonard
Identification of the Key Residues Responsible for the Assembly of Selenodeiodinases
J. Biol. Chem., May 26, 2006; 281(21): 14615 - 14621.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. E. Handy, G. Hang, J. Scolaro, N. Metes, N. Razaq, Y. Yang, and J. Loscalzo
Aminoglycosides Decrease Glutathione Peroxidase-1 Activity by Interfering with Selenocysteine Incorporation
J. Biol. Chem., February 10, 2006; 281(6): 3382 - 3388.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
R. J. Stillwell and M. J. Berry
Expanding the repertoire of the eukaryotic selenoproteome
PNAS, November 8, 2005; 102(45): 16123 - 16124.
[Full Text] [PDF]


Home page
J Mol EndocrinolHome page
G. G J M Kuiper, W. Klootwijk, and T. J Visser
Expression of recombinant membrane-bound type I iodothyronine deiodinase in yeast
J. Mol. Endocrinol., June 1, 2005; 34(3): 865 - 878.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
L. H. Canani, C. Capp, J. M. Dora, E. L. S. Meyer, M. S. Wagner, J. W. Harney, P. R. Larsen, J. L. Gross, A. C. Bianco, and A. L. Maia
The Type 2 Deiodinase A/G (Thr92Ala) Polymorphism Is Associated with Decreased Enzyme Velocity and Increased Insulin Resistance in Patients with Type 2 Diabetes Mellitus
J. Clin. Endocrinol. Metab., June 1, 2005; 90(6): 3472 - 3478.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. E. Handy, Y. Zhang, and J. Loscalzo
Homocysteine Down-regulates Cellular Glutathione Peroxidase (GPx1) by Decreasing Translation
J. Biol. Chem., April 22, 2005; 280(16): 15518 - 15525.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
C. A. Shepherdley, W. Klootwijk, K. W. Makabe, T. J. Visser, and G. G. J. M. Kuiper
An Ascidian Homolog of Vertebrate Iodothyronine Deiodinases
Endocrinology, March 1, 2004; 145(3): 1255 - 1268.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
B. W. Kim, A. M. Zavacki, C. Curcio-Morelli, M. Dentice, J. W. Harney, P. R. Larsen, and A. C. Bianco
Endoplasmic Reticulum-Associated Degradation of the Human Type 2 Iodothyronine Deiodinase (D2) is Mediated via an Association between Mammalian UBC7 and the Carboxyl Region of D2
Mol. Endocrinol., December 1, 2003; 17(12): 2603 - 2612.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
G. G. J. M. Kuiper, F. Wassen, W. Klootwijk, H. van Toor, E. Kaptein, and T. J. Visser
Molecular Basis for the Substrate Selectivity of Cat Type I Iodothyronine Deiodinase
Endocrinology, December 1, 2003; 144(12): 5411 - 5421.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
G. G. J. M. Kuiper, W. Klootwijk, and T. J. Visser
Substitution of Cysteine for Selenocysteine in the Catalytic Center of Type III Iodothyronine Deiodinase Reduces Catalytic Efficiency and Alters Substrate Preference
Endocrinology, June 1, 2003; 144(6): 2505 - 2513.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
C. Curcio-Morelli, B. Gereben, A. M. Zavacki, B. W. Kim, S. Huang, J. W. Harney, P. R. Larsen, and A. C. Bianco
In Vivo Dimerization of Types 1, 2, and 3 Iodothyronine Selenodeiodinases
Endocrinology, March 1, 2003; 144(3): 937 - 946.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
G. G. J. M. Kuiper, W. Klootwijk, and T. J. Visser
Substitution of Cysteine for a Conserved Alanine Residue in the Catalytic Center of Type II Iodothyronine Deiodinase Alters Interaction with Reducing Cofactor
Endocrinology, April 1, 2002; 143(4): 1190 - 1198.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
A. C. Bianco, D. Salvatore, B. Gereben, M. J. Berry, and P. R. Larsen
Biochemistry, Cellular and Molecular Biology, and Physiological Roles of the Iodothyronine Selenodeiodinases
Endocr. Rev., February 1, 2002; 23(1): 38 - 89.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
C. Buettner, J. W. Harney, and P. R. Larsen
The Role of Selenocysteine 133 in Catalysis by the Human Type 2 Iodothyronine Deiodinase
Endocrinology, December 1, 2000; 141(12): 4606 - 4612.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
B. Gereben, C. Goncalves, J. W. Harney, P. R. Larsen, and A. C. Bianco
Selective Proteolysis of Human Type 2 Deiodinase: A Novel Ubiquitin-Proteasomal Mediated Mechanism for Regulation of Hormone Activation
Mol. Endocrinol., November 1, 2000; 14(11): 1697 - 1708.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
M. T. Nasim, S. Jaenecke, A. Belduz, H. Kollmus, L. Flohe, and J. E. G. McCarthy
Eukaryotic Selenocysteine Incorporation Follows a Nonprocessive Mechanism That Competes with Translational Termination
J. Biol. Chem., May 12, 2000; 275(20): 14846 - 14852.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. R. Gasdaska, J. W. Harney, P. Y. Gasdaska, G. Powis, and M. J. Berry
Regulation of Human Thioredoxin Reductase Expression and Activity by 3'-Untranslated Region Selenocysteine Insertion Sequence and mRNA Instability Elements
J. Biol. Chem., September 3, 1999; 274(36): 25379 - 25385.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Buettner, J. W. Harney, and M. J. Berry
The Caenorhabditis elegans Homologue of Thioredoxin Reductase Contains a Selenocysteine Insertion Sequence (SECIS) Element That Differs from Mammalian SECIS Elements but Directs Selenocysteine Incorporation
J. Biol. Chem., July 30, 1999; 274(31): 21598 - 21602.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
H. Huang, N. Marsh-Armstrong, and D. D. Brown
Metamorphosis is inhibited in transgenic Xenopus laevis tadpoles that overexpress type III deiodinase
PNAS, February 2, 1999; 96(3): 962 - 967.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
D Prabakaran, R. Ahima, J. Harney, M. Berry, P. Larsen, and P Arvan
Polarized targeting of epithelial cell proteins in thyrocytes and MDCK cells
J. Cell Sci., January 4, 1999; 112(8): 1247 - 1256.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
W. Wen, S. L. Weiss, and R. A. Sunde
UGA Codon Position Affects the Efficiency of Selenocysteine Incorporation into Glutathione Peroxidase-1
J. Biol. Chem., October 23, 1998; 273(43): 28533 - 28541.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
M. Maiorino, J. B. Wissing, R. Brigelius-Flohé, F. Calabrese, A. Roveri, P. Steinert, F. Ursini, and L. Flohé
Testosterone mediates expression of the selenoprotein PHGPx by induction of spermatogenesis and not by direct transcriptional gene activation
FASEB J, October 1, 1998; 12(13): 1359 - 1370.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
W. Croteau, J. E. Bodwell, J. M. Richardson, and D. L. St. Germain
Conserved Cysteines in the Type 1 Deiodinase Selenoprotein Are Not Essential for Catalytic Activity
J. Biol. Chem., September 25, 1998; 273(39): 25230 - 25236.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
P. M. Moriarty, C. C. Reddy, and L. E. Maquat
Selenium Deficiency Reduces the Abundance of mRNA for Se-Dependent Glutathione Peroxidase 1 by a UGA-Dependent Mechanism Likely To Be Nonsense Codon-Mediated Decay of Cytoplasmic mRNA
Mol. Cell. Biol., May 1, 1998; 18(5): 2932 - 2939.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
B. C. Sun, J. W. Harney, M. J. Berry, and P. R. Larsen
The Role of the Active Site Cysteine in Catalysis by Type 1 Iodothyronine Deiodinase
Endocrinology, December 1, 1997; 138(12): 5452 - 5458.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. R. Bosl, K. Takaku, M. Oshima, S. Nishimura, and M. M. Taketo
Early embryonic lethality caused by targeted disruption of the mouse selenocysteine tRNA gene (Trsp)
PNAS, May 27, 1997; 94(11): 5531 - 5534.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
K. A. Mol, S. van der Geyten, V. M. Darras, T. J. Visser, and E. R. Kuhn
Characterization of Iodothyronine Outer Ring and Inner Ring Deiodinase Activities in the Blue Tilapia, Oreochromis Aureus
Endocrinology, May 1, 1997; 138(5): 1787 - 1793.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
C. Valverde-R, W. Croteau, G. J. LaFleur Jr., A. Orozco, and D. L. St. Germain
Cloning and Expression of a 5'-Iodothyronine Deiodinase from the Liver of Fundulus heteroclitus
Endocrinology, February 1, 1997; 138(2): 642 - 648.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. Croteau, S. L. Whittemore, M. J. Schneider, and D. L. St. Germain
Cloning and Expression of a cDNA for a Mammalian Type III Iodothyronine Deiodinase
J. Biol. Chem., July 14, 1995; 270(28): 16569 - 16575.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Toyoda, M. J. Berry, J. W. Harney, and P. R. Larsen
Topological Analysis of the Integral Membrane Protein, Type 1 Iodothyronine Deiodinase (D1)
J. Biol. Chem., May 19, 1995; 270(20): 12310 - 12318.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. L. Leonard, T. J. Visser, and D. M. Leonard
Characterization of the Subunit Structure of the Catalytically Active Type I Iodothyronine Deiodinase
J. Biol. Chem., January 19, 2001; 276(4): 2600 - 2607.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1992 by The Endocrine Society